508 related articles for article (PubMed ID: 6172517)
1. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
3. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
Holda JH; Swanborg RH
Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
7. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
Hinrichs DJ; Roberts CM; Waxman FJ
J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
[TBL] [Abstract][Full Text] [Related]
8. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
Wegmann KW; Hinrichs DJ
J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
[TBL] [Abstract][Full Text] [Related]
9. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
Vandenbark AA; Gill T; Offner H
J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
[TBL] [Abstract][Full Text] [Related]
10. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
[TBL] [Abstract][Full Text] [Related]
11. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
[TBL] [Abstract][Full Text] [Related]
12. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
Panitch HS; McFarlin DE
J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
[TBL] [Abstract][Full Text] [Related]
13. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1976 Jul; 117(1):110-4. PubMed ID: 58930
[TBL] [Abstract][Full Text] [Related]
14. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
[TBL] [Abstract][Full Text] [Related]
15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
17. The nature of the defect in experimental allergic encephalomyelitis (EAE)-resistant Lewis (Le-R) rats.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1985 Mar; 134(3):1567-70. PubMed ID: 2578512
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
Hayosh NS; Simon LL; Swanborg RH
J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
[TBL] [Abstract][Full Text] [Related]
19. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat.
Hunt DW; Corson L; Barker HD; Levy JG; Petty RE
J Autoimmun; 1993 Dec; 6(6):691-700. PubMed ID: 8155251
[TBL] [Abstract][Full Text] [Related]
20. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
Welch AM; Holda JH; Swanborg RH
J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
